Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Total Liabilities (2016 - 2025)

Ptc Therapeutics has reported Total Liabilities over the past 14 years, most recently at $3.1 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $3.1 billion for Q4 2025, up 10.74% from a year ago — trailing twelve months through Dec 2025 was $3.1 billion (up 10.74% YoY), and the annual figure for FY2025 was $3.1 billion, up 10.74%.
  • Total Liabilities for Q4 2025 was $3.1 billion at Ptc Therapeutics, up from $2.8 billion in the prior quarter.
  • Over the last five years, Total Liabilities for PTCT hit a ceiling of $3.1 billion in Q4 2025 and a floor of $1.8 billion in Q3 2022.
  • Median Total Liabilities over the past 5 years was $2.1 billion (2022), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Total Liabilities: skyrocketed 105.95% in 2021 and later dropped 5.21% in 2022.
  • Ptc Therapeutics' Total Liabilities stood at $1.9 billion in 2021, then grew by 5.99% to $2.1 billion in 2022, then skyrocketed by 32.23% to $2.7 billion in 2023, then increased by 3.27% to $2.8 billion in 2024, then rose by 10.74% to $3.1 billion in 2025.
  • The last three reported values for Total Liabilities were $3.1 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.8 billion (Q2 2025) per Business Quant data.